AstraZeneca Vaccine: Key Facts Around Safety, Risks

AstraZeneca Vaccine: Key Facts Around Safety, Risks

Assessment

Interactive Video

Business, Health Sciences, Social Studies, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the UK's vaccination progress, highlighting over 11 million doses administered and the role of the MHRA and Yellow card system in monitoring anomalies. It addresses concerns about blood clotting incidents, particularly in Germany, and emphasizes the higher risks posed by COVID-19 itself. The global impact of COVID-19 is noted, with 2.7 million deaths and 300 million vaccines administered. The video stresses the importance of restoring confidence in vaccines, especially in Europe, and the need for regulatory bodies to balance risk assessment. It concludes with the challenges of managing the pandemic and the importance of continued vaccination efforts to prevent the spread of variants.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What systems are in place in the UK to monitor adverse effects of COVID-19 vaccines?

The MHRA and the Yellow Card system

The CDC and the Blue Card system

The WHO and the Green Card system

The NHS and the Red Card system

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a significant challenge in identifying vaccine-related blood clotting cases?

Inadequate reporting systems

High incidence of side effects

Difficulty in distinguishing from COVID-19 related clotting

Lack of vaccine availability

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many deaths have been definitively linked to COVID-19 vaccines globally?

1,000

100

10,000

0

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a major concern when suspending vaccinations during a pandemic?

Increased vaccine production

Decreased virus transmission

Growth of virus variants

Improved public health

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a key factor in restoring public confidence in vaccines?

Increasing vaccine prices

Balancing risk assessment by regulatory bodies

Reducing vaccine production

Decreasing public health campaigns